MedPage Today December 16, 2025
The system is far more complex than Trump’s proposal conveys
Americans pay too much for prescription drugs. On that point, there is almost universal agreement.
In 2019, the U.S. spent more than $1,000 per person on prescribed medicines — more than any other high-income nation. An Organization for Economic Cooperation and Development (OECD) analysis put U.S. per-capita retail pharmaceutical spending at more than twice the OECD average. The Kaiser Family Foundation has shown Americans often pay more for the same drugs that cost far less across Europe and other wealthy countries.
Prices must come down, but how we get there matters. A lot.
The Trump Administration’s Proposal
In November, the Trump administration resurrected a Most Favored Nation (MFN) reference pricing...
Today's Sponsors
Today's Sponsor